Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

86 results about "Metallofullerene" patented technology

In chemistry, a metallofullerene is a molecule composed of a metal atom trapped inside a fullerene cage. Simple metallofullerenes consist of a fullerene cage, typically C₈₀, with one or two metal atoms trapped inside. Recently, research has produced metallofullerenes that enclose small clusters of atoms, such as Sc₃N@C₈₀, Y₃N@C₈₀, and Sc₃C₂@C₈₀. The '@' symbol in the formula indicates that the atom(s) are encapsulated inside the cage, rather than being chemically bonded to it.

Metallic fullerene compound as well as preparation method and applications thereof

The invention relates to a metallic fullerene compound as well as a preparation method and applications of the metallic fullerene compound. The metallic fullerene compound is micro-nano particles obtained by compounding metallic fullerene or a derivative of metallic fullerene with a medical carrier through covalent bonds or non-covalent bonds. The preparation method of the metallic fullerene compound comprises the following step: bonding metallic fullerene to the medical carrier through the non-covalent effect or bonding the derivative of metallic fullerene with the medical carrier through the covalent effect. As the medicine for realizing the targeted diagnosis and / or treatment on tumor, the metallic fullerene compound is safe and non-toxic, has the aggregating size being 1-500 nm in an aqueous solution, can be effectively gathered to the tumor location through blood circulation by utilizing the EPP effect, has no toxic or side effect for the normal biological tissue, and has extremely high biosecurity, the targeted diagnosis and / or treatment on malignant tumor is realized, the use dosage of the antitumor drugs is reduced, and meanwhile, the metallic fullerene compound has high tumor targeting property, and has a broad prospect in the diagnosis and treatment integrated application of tumor.
Owner:INST OF CHEM CHINESE ACAD OF SCI

Application of water-soluble fullerene structure for preparing medicine for treating fatty liver

The invention discloses a water-soluble fullerene structure for preparing a medicine for treating fatty liver, and discloses a pharmaceutical composition and a method for treating fatty liver. Activeingredients for treating fatty liver are water-soluble fullerene, water-soluble inlaid metal fullerene, composition of the water-soluble fullerene and the water-soluble inlaid metal fullerene, and pharmaceuitical ester of above three and pharmaceutical salt of the three. The active ingredient water-soluble fullerene structure can reduce fatty vesicles in the liver, lower blood lipids, and obviously improve liver function, so that the content of alanine aminotransferase and aspartate aminotransferase tends to be normal, and the effect of treating fatty liver is highly effective. The active ingredient water-soluble fullerene structure can also regulate the level of redox in the liver.
Owner:BEIJING FUNAKANG BIOTECH CO LTD

Applications of fullerene structure in preparation of drugs used for treating leukemia

The invention discloses applications of a fullerene structure in preparation of drugs used for treating leukemia. The fullerene structure is taken as an active ingredient, and comprises at least one ingredient selected from an oil soluble fullerene, an oil soluble metal embedded fullerene, a composition of the oil soluble fullerene and the oil soluble metal embedded fullerene, a water soluble fullerene, a water soluble metal embedded fullerene, a composition of the water soluble fullerene and the water soluble metal embedded fullerene, and a pharmaceutical ester or a pharmaceutical salt of theabove six ingredients. The active ingredient is capable of accumulating in bone marrow at a high efficiency; effects are achieved quickly; excellent biocompatibility is achieved; the fullerene structure can be used for preventing and treating leukemia before leukemia model maturation; after leukemia onset, the active ingredient possesses bone marrow part targeted enrichment characteristics, and can be used for rapid prevention, treatment, and repairing of bone marrow haematopoietic function damages by leukemia and other organic damages.
Owner:BEIJING FUNAKANG BIOTECH CO LTD

Application of water-soluble fullerene structure in preparation of medicine for treating pulmonary fibrosis

The invention discloses the application of a water-soluble fullerene structure in the preparation of medicine for treating pulmonary fibrosis. The water-soluble fullerene structure comprises a water-soluble fullerene, a water-soluble intercalated metal fullerene, a composition of the water-soluble fullerene and the water-soluble intercalated metal fullerene, a pharmaceutically acceptable ester ofthe above three or a pharmaceutically acceptable salt of the above three. The water-soluble fullerene structure of the invention can treat pulmonary fibrosis, including treating congestion, edema or hyperplasia of the lung, and treating pulmonary collagen fiber hyperplasia and accumulation. Moreover, the active ingredient can be excreted out of the body through metabolism of the organism, has no toxic and side effects, and has good biocompatibility.
Owner:BEIJING FUNAKANG BIOTECH CO LTD

Method for rapidly separating endohedral metallofullerenes

The invention discloses a method for rapidly separating endohedral metallofullerenes and belongs to the field of fullerene separation. The method comprises the following steps: completely dissolving afullerene mixture containing the endohedral metallofullerenes in an organic solvent to obtain a to-be-separated solution; mixing Lewis acid and the to-be-separated solution in a volume ratio being 1:100-1:2000 to obtain a precipitate; washing the precipitate with water to obtain the endohedral metallofullerenes. At least half a month is required for separating the endohedral metallofullerenes from 1 g of the fullerene mixture containing the endohedral metallofullerenes only with the conventional HPLC (high performance liquid chromatography) separation, manual operation is needed all the time,and much time and labor are consumed; while the Lewis acid based separation method is not limited by quantity, a large quantity of the fullerene mixture containing the endohedral metallofullerenes can be subjected to separation within one day, and an endohedral metallofullerene enriched product is obtained.
Owner:HUAZHONG UNIV OF SCI & TECH

Magnetic resonance imaging contrast agent having bone tissue targeting detection based on metal fullerene and the preparation thereof

ActiveCN101062421AExcellent imaging efficiencyEasy to operateNMR/MRI constrast preparationsEthyl groupRaw material
The invention discloses a high effective magnetic resonance image-forming contrast agent with bone tissue target taxis teat base on metallic enriched ocimene and preparing method, which is characterized by the following: setting molecule formula at Gd@C82Ox(OH)y(C(PO3Et2)2)10 or GdaM3-aN@C80Ox(OH)y(C(PO3Et2)2)10 or Gd2@C80Ox(OH)y(C(PO3Et2)2)10; setting a at 1, 2 or 3; setting M as Sc or Er; setting x as 2-8; setting y as 12-16; setting Et as ethyl group; choosing metallic enriched ocimene with Gd as raw material; proceeding Bingel addition reaction with tetraethyl methano diphosphate under existence of NaH; proceeding nucleophilic additive reaction with OH-; synthesizing water-soluble metallic enriched ocimene derivant with outer cage modification phosphatide group with big scale. This invention possesses the advantages of convenient operation and big scale production.
Owner:赤峰福纳康生物技术有限公司 +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products